Related Experiment Video
Updated: Sep 17, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Salen-Type Copper(II) Complexes: Synthesis, Characterization, Computational Studies, Molecular Docking, Anticancer
Abdellatif A Helaly1,2, Bandar A Babgi1, Yoji Kobayashi3
1Department of Chemistry, Faculty of Science, King Abdulaziz University (KAU), Jeddah, 21589, Saudi Arabia.
This study synthesized novel copper(II) complexes with salen-type ligands for cancer treatment. The complex [CuII(salen)(H2O)2] showed promising anticancer activity and lower toxicity than cisplatin.
Area of Science:
- Coordination Chemistry
- Medicinal Chemistry
- Computational Chemistry
Background:
- Transition metal complexes are promising anticancer agents due to their efficacy against cancer cells.
- Organic backbone structures in existing compounds limit their potential against cancer.
- Salen copper(II) complexes offer a potential avenue for improved anticancer therapies.
Purpose of the Study:
- To synthesize and evaluate the anticancer activity of three salen copper(II) complexes.
- To predict the molecular interactions and activity of ligands and complexes using computational methods.
- To assess the therapeutic window by comparing toxicity to normal cells.
Main Methods:
- Synthesis of three salen copper(II) complexes: [CuII(salophen)(H2O)2] (1), [CuII(salen)(H2O)2] (2), and [CuII(etho-salen)(H2O)2] (3).
- Density Functional Theory (DFT) for structure optimization.
- Molecular docking against cyclin-dependent kinase 5 (Cdk5) and aromatase cytochrome (P450).
- In vitro anticancer screening against MCF-7 and HCT-116 cell lines.
Main Results:
- Complex [CuII(salen)(H2O)2] (2) exhibited the best docking scores and lowest RMSD against Cdk5 and P450.
- Complex (2) demonstrated significant anticancer activity with IC50 values of 212.5 μm (MCF-7) and 98.9 μm (HCT-116).
- Complex (2) showed reduced toxicity toward normal HFF-1 fibroblasts compared to cisplatin, suggesting a better therapeutic index.
Conclusions:
- The synthesized salen copper(II) complexes, particularly [CuII(salen)(H2O)2] (2), show potential as anticancer agents.
- Computational docking studies effectively predicted the activity of these complexes.
- The favorable therapeutic window of complex (2) warrants further investigation for clinical applications.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
11:38Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
Published on: April 5, 2022
Related Concept Videos
Extraction: Advanced Methods
Complexation Equilibria: The Chelate Effect
Drug Discovery: Overview
Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Ladder Diagrams: Complexation Equilibria
The formation constant, K1, for the formation of Cd(NH3)2+ complex from cadmium and ammonia is 3.55 × 102. Log K1 (i.e. pNH3) is 2.55, and...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...